Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.

Peterse EFP, Niessen B, Addie RD, de Jong Y, Cleven AHG, Kruisselbrink AB, van den Akker BEWM, Molenaar RJ, Cleton-Jansen AM, Bovée JVMG.

Br J Cancer. 2018 Apr;118(8):1074-1083. doi: 10.1038/s41416-018-0050-9. Epub 2018 Mar 26.

2.

NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma.

Peterse EFP, van den Akker BEWM, Niessen B, Oosting J, Suijker J, de Jong Y, Danen EHJ, Cleton-Jansen AM, Bovée JVMG.

Mol Cancer Res. 2017 Dec;15(12):1714-1721. doi: 10.1158/1541-7786.MCR-17-0293. Epub 2017 Aug 31.

3.

A magnetically shielded room with ultra low residual field and gradient.

Altarev I, Babcock E, Beck D, Burghoff M, Chesnevskaya S, Chupp T, Degenkolb S, Fan I, Fierlinger P, Frei A, Gutsmiedl E, Knappe-Grüneberg S, Kuchler F, Lauer T, Link P, Lins T, Marino M, McAndrew J, Niessen B, Paul S, Petzoldt G, Schläpfer U, Schnabel A, Sharma S, Singh J, Stoepler R, Stuiber S, Sturm M, Taubenheim B, Trahms L, Voigt J, Zechlau T.

Rev Sci Instrum. 2014 Jul;85(7):075106. doi: 10.1063/1.4886146.

PMID:
25085172
4.

[Basic tenets for quality circles in North Rhine Medical Service of Public Health Insurance].

Lauven G, Becker H, Euteneuer H, Greven T, Grossgarten KH, Kost HG, Niessen B, Pichlo HG, Schöngart C, Uphaus W, Vogt R, Hufer H, Müller-Held W.

Z Arztl Fortbild Qualitatssich. 2000 Jan;94(1):71-7. German.

PMID:
10721168

Supplemental Content

Loading ...
Support Center